FotoFinder welcomes GHO Capital Partners as new majority shareholder
The FotoFinder Group is entering a new chapter together with GHO Capital Partners. GHO, a European specialist investor in global healthcare, has acquired a majority stake in FotoFinder. EMZ Partners will remain on board as a minority shareholder.
Since its founding in 1991 by Andreas and Rudolf Mayer, FotoFinder has developed into a global leader in innovative skin imaging solutions. The portfolio includes technology for early skin cancer detection using Total Body Mapping and AI-powered dermoscopy, as well as solutions for hair analysis and aesthetics. With the acquisition of DermLite in 2024, FotoFinder added market-leading analogue dermatoscopes to its offering and created a unique portfolio.
“I am proud of what we have built together over the past three decades,” says Andreas Mayer, CEO of the FotoFinder Group. “Together with EMZ, we have achieved important milestones, especially the acquisition of DermLite. The partnership with GHO represents a new inflection point for the business. With its specialist healthcare industry expertise and unrivalled network, we believe GHO is the ideal partner to support the company in unlocking this next phase of growth.”
John Bottjer, co-founder of DermLite, comments: “The combination of FotoFinder and DermLite has created a truly unique offering for dermatology professionals worldwide. We are excited about the partnership with GHO and confident that their experience and resources will help us further expand our global presence.”
Klaus Maurer, Senior Partner at EMZ Partners, also emphasizes: “Since our entry three years ago, FotoFinder has achieved continued growth, underpinned by its expanded presence in the US market through DermLite. Together with GHO and the strong management team, we have created the best conditions to seize the next growth opportunities. We are looking forward to remaining a shareholder of the Group.”
Ken Eichmann and Stuart Quin, Partners at GHO Capital, add: “FotoFinder is a pioneer in skin imaging and has set new standards with its outstanding innovation. We are excited to partner with Andreas, John and the combined FotoFinder/DermLite team, along with our partners at EMZ, to leverage our experience of scaling international healthcare platforms.”
Rising skin cancer rates, an ageing population, and increasing awareness of regular skin checks are driving global demand for precise diagnostic tools. FotoFinder offers solutions that accelerate diagnoses, streamline workflows, and improve care – making an important contribution to early detection.
“We look forward to continuing this journey together with our teams in Bad Birnbach and Aliso Viejo, as well as our partners and customers,” Andreas Mayer emphasizes. “GHO brings everything needed to support the FotoFinder Group in the next phase of international expansion.”
The transaction is expected to close in the coming weeks, subject to standard regulatory approvals.
